{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:53:00Z","timestamp":1793332380678,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40701"],"award-info":[{"award-number":["2022JJ40701"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0706200"],"award-info":[{"award-number":["2019YFA0706200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021ZD0202000"],"award-info":[{"award-number":["2021ZD0202000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201693"],"award-info":[{"award-number":["82201693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jad.2023.07.078","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T04:54:39Z","timestamp":1689569679000},"page":"624-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"339","author":[{"given":"Wenwen","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.07.078_bb0005","article-title":"The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: a systematic review and meta-analysis","volume":"26","author":"Almulla","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"19","key":"10.1016\/j.jad.2023.07.078_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193112","article-title":"The tryptophan catabolite or kynurenine pathway in a major depressive episode with melancholia, psychotic features and suicidal behaviors: a systematic review and meta-analysis","volume":"11","author":"Almulla","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jad.2023.07.078_bb0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neubiorev.2021.05.018","article-title":"The kynurenine pathway in major depression: what we know and where to next","volume":"127","author":"Brown","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6349","key":"10.1016\/j.jad.2023.07.078_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jad.2023.07.078_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychores.2017.05.016","article-title":"Sleep disturbance and kynurenine metabolism in depression","volume":"99","author":"Cho","year":"2017","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2023.07.078_bb0030","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jad.2023.07.078_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.psyneuen.2015.02.011","article-title":"Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers","volume":"56","author":"Dahl","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2023.07.078_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.jad.2023.07.078_bb0045","doi-asserted-by":"crossref","first-page":"16822","DOI":"10.1038\/s41598-020-73918-z","article-title":"Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis","volume":"10","author":"Erabi","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jad.2023.07.078_bb0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2023.07.078_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2023.07.078_bb0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","article-title":"Does escitalopram reduce neurotoxicity in major depression?","volume":"66-67","author":"Halaris","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.07.078_bb0065","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Choosing effect measures and computing estimates of effect","author":"Higgins","year":"2019"},{"key":"10.1016\/j.jad.2023.07.078_bb0070","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Hopkins","year":"2009"},{"key":"10.1016\/j.jad.2023.07.078_bb0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","article-title":"Effect of immune activation on the kynurenine pathway and depression symptoms - a systematic review and meta-analysis","volume":"118","author":"Hunt","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.jad.2023.07.078_bb0080","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1038\/s41380-019-0589-8","article-title":"The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response","volume":"26","author":"Kadriu","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2023.07.078_bb0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition","volume":"22","author":"Keller","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2023.07.078_bb0090","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.jad.2023.07.078_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00702-011-0668-8","article-title":"New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid\/3-hydroxykynurenine ratio","volume":"119","author":"Kocki","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jad.2023.07.078_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2018.07.040","article-title":"Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: an exploratory pilot case-control study","volume":"240","author":"Kuwano","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.07.078_bb0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1742-2094-10-87","article-title":"Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors","volume":"10","author":"Lawson","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2023.07.078_bb0110","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1","article-title":"Chapter 6: searching for studies","author":"Lefebvre","year":"2011"},{"key":"10.1016\/j.jad.2023.07.078_bb0115","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fpsyt.2018.00552","article-title":"The metabolic factor Kynurenic acid of kynurenine pathway predicts major depressive disorder","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2023.07.078_bb0120","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat. Methods Med. Res."},{"issue":"1","key":"10.1016\/j.jad.2023.07.078_bb0125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12035-018-1096-7","article-title":"Chronic mild stress alters kynurenine pathways changing the glutamate neurotransmission in frontal cortex of rats","volume":"56","author":"Mart\u00edn-Hern\u00e1ndez","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.jad.2023.07.078_bb0130","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies","volume":"26","author":"Marx","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2023.07.078_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.07.078_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbi.2020.12.033","article-title":"Stress impairs response to antidepressants via HPA axis and immune system activation","volume":"93","author":"Menke","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.07.078_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbi.2021.07.007","article-title":"The association between plasma tryptophan catabolites and depression: the role of symptom profiles and inflammation","volume":"97","author":"Milaneschi","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.07.078_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2023.07.078_bb0155","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence","author":"Moncrieff","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2023.07.078_bb0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1176\/appi.ajp.2020.20060845","article-title":"The state of our understanding of the pathophysiology and optimal treatment of depression: glass half full or half empty?","volume":"177","author":"Nemeroff","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.07.078_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2017.09.014","article-title":"Plasma amino acid profile in major depressive disorder: analyses in two independent case-control sample sets","volume":"96","author":"Ogawa","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.07.078_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: a systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.jad.2023.07.078_bb0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jclinepi.2009.03.009","article-title":"AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program","volume":"63","author":"Owens","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2023.07.078_bb0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","article-title":"Peripheral and central kynurenine pathway abnormalities in major depression","volume":"101","author":"Paul","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.jad.2023.07.078_bb0185","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.07.078_bb0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2023.07.078_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.07.078_bb0200","article-title":"Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid","volume":"1-10","author":"Savitz","year":"2020","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jad.2023.07.078_bb0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","article-title":"Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients","volume":"13","author":"Schwieler","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jad.2023.07.078_bb0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2023.07.078_bb0215","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbi.2019.04.032","article-title":"Interferon-alpha-induced depression: comparisons between early- and late-onset subgroups and with patients with major depressive disorder","volume":"80","author":"Su","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.07.078_bb0220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbi.2020.01.011","article-title":"The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine","volume":"87","author":"Sun","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jad.2023.07.078_bb0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12640-017-9714-0","article-title":"Correlations of Kynurenic acid, 3-Hydroxykynurenine, sIL-2R, IFN-\u03b1, and IL-4 with clinical symptoms during acute relapse of schizophrenia","volume":"32","author":"Szymona","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jad.2023.07.078_bb0230","series-title":"R: A Language and Environment for Statistical Computing","first-page":"12","volume":"14","author":"Team, R. J. C","year":"2009"},{"key":"10.1016\/j.jad.2023.07.078_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"4","key":"10.1016\/j.jad.2023.07.078_bb0240","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1037\/1082-989X.6.4.413","article-title":"The role of method in treatment effectiveness research: evidence from meta-analysis","volume":"6","author":"Wilson","year":"2001","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.jad.2023.07.078_bb0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2016.04.007","article-title":"Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression","volume":"56","author":"Young","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.07.078_bb0250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2018.09.007","article-title":"Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression","volume":"74","author":"Zhou","year":"2018","journal-title":"Brain Behav. Immun."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723009291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723009291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T17:51:58Z","timestamp":1727286718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723009291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"alternative-id":["S0165032723009291"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.07.078","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.07.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}